K-ras gene mutation status in colorectal cancer: Comparative analysis of pyrosequencing and pcr-rflp

Romanian Journal of Morphology and Embryology

Volumn 54, Issue 3, 2013, Pages 567-574

  Dobre, Maria ^a   Comǎnescu, Maria ^a   Arsene, D ^a   Iosif, Cristina ^a   Bussolati, G ^a  

^a VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

Colon cancer; K ras mutation; Pyrosequencing

Indexed keywords

ARTICLE; CODON; COLORECTAL TUMOR; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; HUMAN; METHODOLOGY; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PATHOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BASE SEQUENCE; CODON; COLORECTAL NEOPLASMS; GENES, RAS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA;

EID: 84884541805     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Stec R, Bodnar L, Charkiewicz R, Korniluk J, Rokita M, Smoter M, Ciechowicz M, Chyczewski L, Nikliński J, Koztowski W, Szczylik C, K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy, Cancer Biol Ther, 2012, 13(13):1235-1243.
2. Enrique AA, Gema PC, Jeronimo JC, Auxiliadora GE, Role of anti-EGFR target therapy in colorectal carcinoma, Front Biosci (Elite Ed), 2012, 4:12-22.
3. Popa C, Ionescu S, Mihǎilǎ D, Gal I, Potecǎ T, Simion S, Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies, J Med Life, 2012, 5(2):168-172.
4. Ney JT, Froehner S, Roesler A, Buettner R, Merkelbach-Bruse S, High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS, BRAF, PIK3CA, and AKT1 mutations in formalin-fixed, paraffin-embedded tissues, Arch Pathol Lab Med, 2012, 136(9):983-992.
5. Heinemann V, Stintzing S, Kirchner T, Boeck S, Jung A, Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR, Cancer Treat Rev, 2009, 35(3):262-271.
6. Lièvre A, Blons H, Laurent-Puig P, Oncogenic mutations as predictive factors in colorectal cancer, Oncogene, 2010, 29(21):3033-3043.
7. Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE, Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases, Clin Cancer Res, 2010, 16(3):790-799.
8. Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A, Domingo E, Capelinha AF, Duval A, Hamelin R, Machado JC, Schwartz S Jr, Carneiro F, Seruca R, KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression, Oncogene, 2007, 26(1):158-163.
9. Kiaris H, Spandidos D, Mutations of ras genes in human tumours (review), Int J Oncol, 1995, 7(3):413-421.
10. Russo A, Bazan V, Agnese V, Rodolico V, Gebbia N, Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies, Ann Oncol, 2005, 16(Suppl 4):444-449.
11. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE, Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status, Nature, 2002, 418(6901):934.
12. Bazan V, Agnese V, Corsale S, Calò V, Valerio MR, Latteri MA, Vieni S, Grassi N, Cicero G, Dardanoni G, Tomasino RM, Colucci G, Gebbia N, Russo A; Gruppo Oncologico dell'Italia Meridionale (GOIM), Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study, Ann Oncol, 2005, 16(Suppl 4):450-455.
13. Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH, Pachen MM, Smits KM, de Bruïne AP, Goldbohm RA, van den Brandt PA, K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study, Carcinogenesis, 2003, 24(4):703-710.
14. Chang YS, Yeh KT, Hsu NC, Lin SH, Chang TJ, Chang JG, Detection of N-, H-, and KRAS codons 12, 13, and 61 mutations with universal RAS primer multiplex PCR and N-, H-, and KRAS-specific primer extension, Clin Biochem, 2010, 43(3):296-301.
15. Saif MW, Shah M, K-ras mutations in colorectal cancer: a practice changing discovery, Clin Adv Hematol Oncol, 2009, 7(1):45-53, 64.
16. Li Z, Chen Y, Wang D, Wang G, He L, Suo J, Detection of KRAS mutations and their associations with clinicopathological features and survival in Chinese colorectal cancer patients, J Int Med Res, 2012, 40(4):1589-1598.
17. Poehlmann A, Kuester D, Meyer F, Lippert H, Roessner A, Schneider-Stock R, K-ras mutation detection in colorectal cancer using the pyrosequencing technique, Pathol Res Pract, 2007, 203(7):489-497.
18. Morelli MP, Kopetz S, Hurdles and complexities of codon 13 KRAS mutations, J Clin Oncol, 2012, 30(29):3565-3567.
19. th edition, IARC Press, Lyon, 2010,134-146.
20. Kubrusly MS, Cunha JE, Bacchella T, Abdo EE, Jukemura J, Penteado S, Morioka CY, de Souza LJ, Machado MC, Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic, JOP, 2002, 3(5): 144-151.
21. Hatzaki A, Razi E, Anagnostopoulou K, Iliadis K, Kodaxis A, Papaioannou D, Labropoulos S, Vasilaki M, Kosmidis P, Saetta A, Mihalatos M, Nasioulas G, A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients, Mol Cell Probes, 2001, 15(5): 243-247.
22. Pérez-Ruiz E, Rueda A, Pereda T, Alcaide J, Bautista D, Rivas-Ruiz F, Villatoro R, Pérez D, Redondo M, Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients, Tumour Biol, 2012, 33(6):1829-1835.
23. Oliveira C, Westra JL, Arango D, Ollikainen M, Domingo E, Ferreira A, Velho S, Niessen R, Lagerstedt K, Alhopuro P, Laiho P, Veiga I, Teixeira MR, Ligtenberg M, Kleibeuker JH, Sijmons RH, Plukker JT, Imai K, Lage P, Hamelin R, Albuquerque C, Schwartz S Jr, Lindblom A, Peltomaki P, Yamamoto H, Aaltonen LA, Seruca R, Hofstra RM, Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status, Hum Mol Genet, 2004, 13(19):2303-2311.
24. McLellan EA, Owen RA, Stepniewska KA, Sheffield JP, Lemoine NR, High frequency of K-ras mutations in sporadic colorectal adenomas, Gut, 1993, 34(3):392-396.